PubRank

T M Coffman

Author PubWeight™ 98.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science 1995 4.55
2 Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci U S A 1995 3.54
3 Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995 3.46
4 Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Invest 2001 2.86
5 The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature 1997 2.56
6 Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999 2.25
7 Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. Proc Natl Acad Sci U S A 1998 2.17
8 Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J Clin Invest 2001 1.99
9 Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 1999 1.80
10 Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J Clin Invest 1997 1.77
11 Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest 1999 1.66
12 Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am J Physiol 1997 1.64
13 The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J Clin Invest 2001 1.60
14 Divergent functions of angiotensin II receptor isoforms in the brain. J Clin Invest 2000 1.59
15 Altered inflammatory responses in leukotriene-deficient mice. Proc Natl Acad Sci U S A 1994 1.59
16 In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 1995 1.56
17 A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J Immunol 2000 1.49
18 Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest 1998 1.46
19 Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect. J Clin Invest 1992 1.45
20 Identification of specific EP receptors responsible for the hemodynamic effects of PGE2. Am J Physiol 1999 1.33
21 Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation. J Clin Invest 2001 1.29
22 Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. Hypertension 2000 1.26
23 Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am J Physiol 1998 1.25
24 Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo. Circulation 2000 1.21
25 Failure of spermatogenesis in mouse lines deficient in the Na(+)-K(+)-2Cl(-) cotransporter. J Clin Invest 2000 1.17
26 Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am J Physiol 1998 1.16
27 Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. Am J Physiol Renal Physiol 2000 1.15
28 Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Int 1995 1.11
29 Renal function in the AT1A receptor knockout mouse during normal and volume-expanded conditions. Kidney Int 1999 1.06
30 Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase. J Am Soc Nephrol 2001 1.04
31 Chronic rejection of mouse kidney allografts. Kidney Int 1999 1.02
32 Exploring type I angiotensin (AT1) receptor functions through gene targeting. Acta Physiol Scand 2004 1.01
33 Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting. Trends Endocrinol Metab 2000 0.99
34 Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. J Immunol 1994 0.98
35 Enhanced renal leukotriene production in murine lupus: role of lipoxygenase metabolites. Kidney Int 1991 0.97
36 Immune cells in a mouse airway model of obliterative bronchiolitis. Am J Respir Cell Mol Biol 1998 0.97
37 Neuroendocrine effects of dehydration in mice lacking the angiotensin AT1a receptor. Hypertension 1999 0.96
38 Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. Clin Immunol Immunopathol 1992 0.92
39 Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2. J Clin Invest 1997 0.91
40 Renal vascular reactivity in mice: AngII-induced vasoconstriction in AT1A receptor null mice. J Am Soc Nephrol 1999 0.90
41 Systemic autoimmune nephritogenic components induce CSF-1 and TNF-alpha in MRL kidneys. Kidney Int 1997 0.90
42 Angiotensin-II-receptors: new targets for antihypertensive therapy. Clin Cardiol 1997 0.90
43 Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am J Physiol 1998 0.90
44 Role of EP(2) and EP(3) PGE(2) receptors in control of murine renal hemodynamics. Am J Physiol Heart Circ Physiol 2001 0.89
45 Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Int 1992 0.88
46 Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts. J Clin Invest 1998 0.86
47 Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney. Clin Pharmacol Ther 1980 0.86
48 Deficiency of 5-lipoxygenase abolishes sex-related survival differences in MRL-lpr/lpr mice. J Immunol 1999 0.86
49 The intragraft CD8+ T cell response in renal allograft rejection in the mouse. Transplantation 1996 0.84
50 Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition. Kidney Int 2001 0.84
51 Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995 0.84
52 Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation 1987 0.83
53 Enhanced central response to dehydration in mice lacking angiotensin AT(1a) receptors. Am J Physiol Regul Integr Comp Physiol 2001 0.82
54 Thromboxane binding and signal transduction in rat glomerular mesangial cells. Am J Physiol 1993 0.82
55 A genetic approach for studying the role of thromboxane A2 in the kidney. Kidney Int Suppl 1998 0.82
56 A role for leukotrienes in cyclosporine nephrotoxicity. Kidney Int 2000 0.81
57 Distribution of binding sites for thromboxane A2 in the mouse kidney. Am J Physiol 1996 0.81
58 Transgenic mice as a tool to study the renin-angiotensin system. Contrib Nephrol 2001 0.81
59 Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol 1986 0.81
60 Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts. Transplantation 2000 0.81
61 Characterization of glomerular thromboxane receptors in murine lupus nephritis. J Pharmacol Exp Ther 1993 0.80
62 The azaspirane SKF 105685 ameliorates renal allograft rejection in rats. J Am Soc Nephrol 1993 0.80
63 Effects of low-dose aspirin therapy on plasma levels of polyunsaturated fatty acids: a preliminary investigation. Am J Perinatol 1995 0.80
64 Physiologic role for enhanced renal thromboxane production in murine lupus nephritis. Prostaglandins 1991 0.80
65 Functional role of thromboxane production by acutely rejecting renal allografts in rats. J Clin Invest 1985 0.80
66 Gene-targeting studies of the renin-angiotensin system: mechanisms of hypertension and cardiovascular disease. Cold Spring Harb Symp Quant Biol 2002 0.79
67 Fish oil feeding modulates leukotriene production in murine lupus nephritis. Prostaglandins 1994 0.79
68 The allocation of cadaver kidneys for transplantation in the United States: consensus and controversy. ASN Transplant Advisory Group. American Society of Nephrology. J Am Soc Nephrol 1999 0.79
69 Rejection of kidney allografts by MHC class I-deficient mice. Transplantation 1995 0.79
70 Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice. Kidney Int 1996 0.79
71 Vasoconstrictor responses in thromboxane receptor knockout mice: tubuloglomerular feedback and ureteral obstruction. Acta Physiol Scand 2000 0.78
72 Effects of thromboxane synthase inhibition with CGS 13080 in human cyclosporine nephrotoxicity. Kidney Int 1992 0.78
73 Atrial natriuretic peptide-induced changes in renal prostacyclin production in ureteral obstruction. Am J Physiol 1990 0.78
74 Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. J Immunol 2001 0.78
75 Role of platelet activating factor in kidney transplant rejection in the rat. Kidney Int 1995 0.77
76 The effects of surgery and acute rejection on glomerular hemodynamics in the transplanted rat kidney. Transplantation 1993 0.77
77 Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice. J Am Soc Nephrol 1999 0.77
78 Gene targeting: applications in transplantation research. Kidney Int 1999 0.77
79 Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. Kidney Int 1999 0.76
80 Alterations in renal interleukin-1 production during kidney transplant rejection in the rat. The effects of high-dose methylprednisolone. Transplantation 1993 0.76
81 The C-terminus of the thromboxane receptor contributes to coupling and desensitization in a mouse mesangial cell line. J Pharmacol Exp Ther 1997 0.76
82 Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. J Heart Lung Transplant 1999 0.76
83 A role for T cell co-stimulation in ischemic acute renal failure? Kidney Int 1997 0.75
84 Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts. Transplantation 1989 0.75
85 Comparison of intravenous digital subtraction angiography and conventional arteriography in defining renal anatomy. Transplantation 1988 0.75
86 Late withdrawal of cyclosporine in stable renal transplant recipients. Am J Kidney Dis 1995 0.75
87 Circadian rhythms of activity and drinking in mice lacking angiotensin II 1A receptors. Physiol Behav 2002 0.75
88 High-protein feeding stimulates renal thromboxane production in rats with streptozocin-induced diabetes. J Lab Clin Med 1989 0.75
89 Bilateral native nephrectomy improves renal isograft function in rats. Kidney Int 1986 0.75
90 What can knockout mice contribute to an understanding of hypertension? Curr Hypertens Rep 2000 0.75
91 Immunologic mechanisms of transplant rejection. Curr Opin Nephrol Hypertens 1992 0.75
92 Associations between rat renal allograft function, inflammation, and host immunity. Transplant Proc 1987 0.75
93 Effect of low-dose aspirin on thromboxane production and the antihypertensive effect of captopril. J Am Soc Nephrol 1993 0.75
94 Genetic manipulation of the renin-angiotensin system. Curr Opin Nephrol Hypertens 1999 0.75
95 Evidence that pretransplant donor blood transfusion prevents rat renal allograft dysfunction but not the in situ cellular alloimmune or morphologic manifestations of rejection. Transplantation 1988 0.75
96 Modulation of thromboxane receptor activation in rat glomerular mesangial cells. Am J Physiol 1994 0.75